Prenetics Global Ltd
corporate_fare Company Profile
Prenetics Global Ltd (NASDAQ:PRE) is a publicly traded company in the Life Sciences sector. Wiseek monitors PRE SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Prenetics' IM8 Closes $1B Non-Dilutive Growth Financing from General Catalyst
- IM8 Lands $1B Non-Dilutive Financing from General Catalyst; Prenetics Lifts Guidance
- Prenetics Global Stock Plunges 8% as Q1 Loss Widens Beyond Analyst Estimates
- Prenetics Global Finalizes Q1 Results, Confirms Strong IM8 Growth & Raised Guidance
- Prenetics Global Reports Q1 Loss of $1.36 Per Share
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for PRE, detected from its recent SEC filings · based on capital-structure filings through 2026-03-31.
Registration of Shares for Resale · Shares from In-the-Money Warrants
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
PRE files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.